Cellanyx
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
100 Cummings Ctr Ste 451C, Beverly, Mass...Phone Number
(978) 473-7883Website
www.cellanyx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cellanyx
Cellanyx is an emerging biotech company focused on advancing proprietary phenotypic biomarker tests utilizing Machine Vision and AI-driven analysis of live single tumor cells. Their innovative approach aims to enhance risk stratification and clinical decision-making for various solid tumors, including prostate, breast, kidney, bladder, and lung cancers. The company provides increased confidence for patients and clinicians through its Laboratory Developed Test (LDT) while also offering cost reduction benefits for third-party payors. Investors are attracted to Cellanyx's first-in-class, clinically-proven, and scalable cancer risk stratification tests that improve treatment actionability and outcomes.Explore more
Cellanyx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cellanyx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Cellanyx has new funding data
Click to see if Cellanyx had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Cellanyx recently announced quarterly report
Check if Cellanyx has recently received funding, and reach out quickly before it becomes old news!
Check out if Cellanyx is spiking on competitors!
Website visits: Recent activity has been detected on your website
Cellanyx, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Cellanyx launches new products
Congratulate Masked Content for being promoted to Masked Content at Cellanyx
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Cellanyx
Compare insights from companies similar to Cellanyx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cellanyx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cellanyx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cellanyx.
Cellanyx Tech Stack
A closer look at the technologies used by Cellanyx
See more technologies
Cellanyx News & Media
Cellanyx Announces Appointment of Guy Fish, MD, MBA to its Leadership Team
BEVERLY, Mass.--(BUSINESS WIRE)--Cellanyx announces appointment of Guy Fish, MD, MBA to its leadership team.Cellanyx Publishes Clinical Proof-of-Concept Study in Urology of First-in-Class Live Tumor Cell, Phenotypic Biomarker Test to Risk Stratify Prostate Cancer Patients
BEVERLY, Mass.--(BUSINESS WIRE)--Cellanyx publishes clinical proof-of-concept study in Urology of live tumor cell, phenotypic biomarker test to risk stratify prostate cancer patientsCellanyx Publishes Details of Novel, First-in-Class Live Tumor Cell Phenotypic Test to Risk-Stratify Aggressive Vs. Indolent Disease Risk in Solid Tumors
BEVERLY, Mass.--(BUSINESS WIRE)--Cellanyx reports first studies showing the potential of a novel, live cancer cell phenotypic test to risk stratify patients with solid tumors
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Cellanyx
Sign Up For FreeTo access detailed company insights
Cellanyx is an emerging biotech company focused on advancing proprietary phenotypic biomarker tests utilizing Machine Vision and AI-driven analysis of live single tumor cells. Their innovative approach aims to enhance risk stratification and clinical decision-making for various solid tumors, including prostate, breast, kidney, bladder, and lung can... Read More
